Altimmune Shares Up 20% Upon Forming Partnership for Intranasal COVID-19 Vaccine: https://t.co/B51ZSBK7kL

The company is collaborating with DynPort on U.S. government funding efforts for its COVID-19 vaccine candidate.

$ALT #covid19 #vaccine #healthcare #stocks https://t.co/jWqvH570QN